Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Diabetes Mellitus, Insulin-Dependent, 12
×
spartalizumab
×
Clear all
Filters
3
NCT05751928
2025-07-08
NEO-MIMAJOR
Biocad
Phase 3
Active not recruiting
411 enrolled
NCT03058289
2025-02-27
IT-01
Intensity Therapeutics, Inc.
Phase 1/2
Completed
111 enrolled
21 charts